Document Classification

Section Type: RESULTS

Text: Rifaximin group also showed significant reduction in mean number of abnormal NP tests (baseline, 2. 35 (95 % confidence interval (CI), 2. 17-2. 53) ; 2 weeks, 1. 29 (95 % CI, 1. 02-1. 56), P = 0. 002 ; 8 weeks, 0. 81 (95 % CI, 0. 61-1. 02), P = 0. 000), compared with placebo group (baseline, 2. 31 (95 % CI, 2. 03-2. 59) ; 2 weeks, 2. 03 (95 % CI, 1. 74-2. 31) ; 8 weeks, 1. 97 (95 % CI, 1. 69-2. 25), P > 0. 05).